Diagnosis  	Diagnosis  	 NNP	O
and  	and  	 CC	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
primary  	primary  	 JJ	B-NP
adult  	adult  	 NN	I-NP
renal  	renal  	 JJ	I-NP
sarcoma  	sarcoma  	 NN	I-NP
To  	To  	 TO	O
investigate  	investigate  	 VB	O
the  	the  	 DT	O
clinical  	clinical  	 JJ	B-NP
characteristics  	characteristics  	 NNS	I-NP
of  	of  	 IN	I-NP
primary  	primary  	 JJ	I-NP
adult  	adult  	 NN	I-NP
renal  	renal  	 JJ	I-NP
sarcoma 	sarcoma 	 NN	I-NP
.  	.  	 .	O
A  	A  	 DT	O
total  	total  	 NN	O
of  	of  	 IN	O
1654  	1654  	 CD	O
cases  	cases  	 NNS	O
with  	with  	 IN	O
adult  	adult  	 JJ	O
renal  	renal  	 JJ	B-NP
tumors  	tumors  	 NNS	I-NP
were  	were  	 VBD	O
treated  	treated  	 VBN	O
during  	during  	 IN	O
1985  	1985  	 CD	O
to  	to  	 TO	O
2009  	2009  	 CD	O
in  	in  	 IN	O
Peking  	Peking  	 NNP	O
Union  	Union  	 NNP	O
Medical  	Medical  	 NNP	O
College  	College  	 NNP	O
Hospital 	Hospital 	 NNP	O
.  	.  	 .	O
Of  	Of  	 IN	O
all 	all 	 DT	O
,  	,  	 ,	O
17  	17  	 CD	O
cases  	cases  	 NNS	O
were  	were  	 VBD	O
diagnosed  	diagnosed  	 VBN	O
as  	as  	 IN	O
primary  	primary  	 JJ	B-NP
renal  	renal  	 JJ	I-NP
sarcoma  	sarcoma  	 NN	I-NP
and  	and  	 CC	O
underwent  	underwent  	 VBD	O
radical  	radical  	 JJ	B-NP
nephrectomy 	nephrectomy 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
clinical  	clinical  	 JJ	B-NP
features  	features  	 NNS	I-NP
of  	of  	 IN	O
17  	17  	 CD	O
such  	such  	 JJ	O
patients  	patients  	 NNS	O
were  	were  	 VBD	O
retrospectively  	retrospectively  	 JJ	O
analyzed 	analyzed 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
first  	first  	 JJ	O
symptom  	symptom  	 NN	B-NP
of  	of  	 IN	O
10  	10  	 CD	O
( 	( 	 -LRB-	O
59 	59 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
cases  	cases  	 NNS	O
in  	in  	 IN	O
all  	all  	 DT	O
renal  	renal  	 JJ	B-NP
sarcomas  	sarcomas  	 NN	I-NP
was  	was  	 VBD	O
abdominal  	abdominal  	 JJ	B-NP
mass 	mass 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
pathological  	pathological  	 JJ	B-NP
diagnosis  	diagnosis  	 NN	I-NP
was  	was  	 VBD	O
leiomyosarcoma  	leiomyosarcoma  	 NNS	B-NP
( 	( 	 -LRB-	O
7  	7  	 CD	O
cases 	cases 	 NNS	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
rhabdomyosarcoma  	rhabdomyosarcoma  	 NNS	B-NP
( 	( 	 -LRB-	O
2  	2  	 CD	O
cases 	cases 	 NNS	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
malignant  	malignant  	 FW	O
fibrous  	fibrous  	 FW	B-NP
histiocytoma  	histiocytoma  	 FW	I-NP
( 	( 	 -LRB-	O
2  	2  	 CD	O
cases 	cases 	 NNS	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
low-differentiated  	low-differentiated  	 JJ	O
sarcoma  	sarcoma  	 NNS	B-NP
( 	( 	 -LRB-	O
2  	2  	 CD	O
cases 	cases 	 NNS	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
chromophobe  	chromophobe  	 FW	B-NP
renal  	renal  	 FW	I-NP
cell  	cell  	 FW	I-NP
carcinoma  	carcinoma  	 FW	I-NP
coexisting  	coexisting  	 FW	O
with  	with  	 FW	O
liposarcoma  	liposarcoma  	 FW	B-NP
( 	( 	 -LRB-	O
1  	1  	 CD	O
case 	case 	 NN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
fibrosarcoma  	fibrosarcoma  	 NNS	B-NP
( 	( 	 -LRB-	O
1  	1  	 CD	O
case 	case 	 NN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
embryonic  	embryonic  	 JJ	B-NP
sarcoma  	sarcoma  	 NNS	I-NP
( 	( 	 -LRB-	O
1  	1  	 CD	O
case 	case 	 NN	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
leiomyosarcoma  	leiomyosarcoma  	 NNS	B-NP
( 	( 	 -LRB-	O
1  	1  	 CD	O
case 	case 	 NN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
One  	One  	 CD	O
patient  	patient  	 NN	O
died  	died  	 VBD	O
of  	of  	 IN	O
tumor  	tumor  	 NN	B-NP
thrombus  	thrombus  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
inferior  	inferior  	 JJ	O
vena  	vena  	 JJ	B-NP
cava  	cava  	 NN	I-NP
during  	during  	 IN	O
surgery 	surgery 	 NN	O
.  	.  	 .	O
Finally 	Finally 	 RB	O
,  	,  	 ,	O
15  	15  	 CD	O
cases  	cases  	 NNS	O
were  	were  	 VBD	O
regularly  	regularly  	 RB	O
followed  	followed  	 VBN	O
up  	up  	 RP	O
for  	for  	 IN	O
4  	4  	 CD	O
to  	to  	 TO	O
60  	60  	 CD	O
months 	months 	 NNS	O
.  	.  	 .	O
Till  	Till  	 IN	O
now 	now 	 RB	O
,  	,  	 ,	O
1  	1  	 CD	O
had  	had  	 VBD	O
tumor-free  	tumor-free  	 JJ	B-NP
survival  	survival  	 NN	I-NP
for  	for  	 IN	O
9  	9  	 CD	O
months 	months 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
other  	other  	 JJ	O
14  	14  	 CD	O
cases  	cases  	 NNS	O
died  	died  	 VBD	O
2-38  	2-38  	 CD	O
months  	months  	 NNS	O
after  	after  	 IN	O
the  	the  	 DT	O
operation  	operation  	 NN	O
with  	with  	 IN	O
a  	a  	 DT	O
median  	median  	 JJ	B-NP
survival  	survival  	 NN	I-NP
time  	time  	 NN	I-NP
of  	of  	 IN	O
18  	18  	 CD	O
( 	( 	 -LRB-	O
range 	range 	 NN	O
,  	,  	 ,	O
5-60 	5-60 	 CD	O
)  	)  	 -RRB-	O
months 	months 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
median  	median  	 JJ	B-NP
survival  	survival  	 NN	I-NP
time  	time  	 NN	I-NP
of  	of  	 IN	I-NP
leiomyosarcoma  	leiomyosarcoma  	 JJ	I-NP
group  	group  	 NN	I-NP
was  	was  	 VBD	O
28  	28  	 CD	O
( 	( 	 -LRB-	O
range 	range 	 NN	O
,  	,  	 ,	O
11-60 	11-60 	 CD	O
)  	)  	 -RRB-	O
months 	months 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
2  	2  	 CD	O
cases  	cases  	 NNS	O
of  	of  	 IN	O
malignant  	malignant  	 JJ	O
fibrous  	fibrous  	 JJ	B-NP
histiocytoma  	histiocytoma  	 NN	I-NP
died  	died  	 VBD	O
4  	4  	 CD	O
and  	and  	 CC	O
8  	8  	 CD	O
months  	months  	 NNS	O
after  	after  	 IN	O
the  	the  	 DT	O
operation  	operation  	 NN	O
respectively 	respectively 	 RB	O
.  	.  	 .	O
The  	The  	 DT	O
primary  	primary  	 JJ	B-NP
renal  	renal  	 JJ	I-NP
sarcoma  	sarcoma  	 NN	I-NP
has  	has  	 VBZ	O
the  	the  	 DT	O
clinical  	clinical  	 JJ	B-NP
symptom  	symptom  	 JJ	I-NP
similar  	similar  	 JJ	O
with  	with  	 IN	O
advanced  	advanced  	 JJ	O
renal  	renal  	 JJ	B-NP
cell  	cell  	 NN	I-NP
carcinoma  	carcinoma  	 NNS	I-NP
and  	and  	 CC	O
has  	has  	 VBZ	O
poor  	poor  	 JJ	O
prognosis 	prognosis 	 NN	O
.  	.  	 .	O
Leiomyosarcoma  	Leiomyosarcoma  	 NNP	B-NP
might  	might  	 MD	O
have  	have  	 VB	O
relative  	relative  	 JJ	B-NP
good  	good  	 JJ	I-NP
prognosis 	prognosis 	 NN	I-NP
.  	.  	 .	O
